Search for: "IPR Pharmaceuticals, Inc."
Results 41 - 60
of 182
Sorted by Relevance
|
Sort by Date
20 Jul 2018, 11:44 pm
The outcome:Mylan Pharmaceuticals, Inc., petitioned for interpartes review (“IPR”) of various patents owned by Allergan,Inc., relating to its dry eye treatment Restasis. [read post]
17 Apr 2015, 12:05 pm
Cir.2015).We then review that construction according to the standard set forth in Teva Pharmaceuticals U.S.A., Inc. v. [read post]
17 May 2018, 7:30 pm
Mylan Pharmaceuticals Inc. [read post]
11 Nov 2015, 4:51 am
In this patent infringement action, Watson Laboratories, Inc.'s ("Watson") moved to dismiss several counts of the complaint filed by Jazz Pharmaceuticals, Inc. and Jazz Pharmaceuticals Ireland Limited (collectively, "Jazz"). [read post]
9 Apr 2015, 7:10 am
" Senju Pharmaceutical Co., Ltd. et al v. [read post]
30 Dec 2017, 8:42 pm
Matal • Trends in Pharmaceutical... [read post]
1 Mar 2019, 5:15 am
Momenta Pharm., Inc. v. [read post]
27 Sep 2020, 6:36 pm
Mylan Pharmaceuticals Inc., No. 19-1451; Arthrex, Inc. v. [read post]
7 Jun 2021, 6:55 am
Hikma Pharmaceuticals USA Inc., No. 20-1119; Attorney Fees: Roadie, Inc. v. [read post]
25 Aug 2015, 12:07 pm
ResQNet.com, Inc. v. [read post]
12 Apr 2017, 9:52 am
(collectively, Novartis).The Board instituted IPRs on all claims of the ’283 patentbased on petitions filed by Torrent PharmaceuticalsLimited, Apotex, Inc. and Mylan Pharmaceuticals Inc. [read post]
29 Nov 2023, 5:00 am
In Allgenesis Biotherapeutics Inc. v. [read post]
19 Nov 2019, 4:22 am
Cir. 2019) (retroactive preclusion based upon IPR decision) The Chamberlain Group, Inc. v. [read post]
24 Oct 2018, 1:47 pm
Mylan Pharmaceuticals Inc., App. [read post]
13 Apr 2017, 9:44 am
In Amerigen Pharmaceuticals Ltd. v. [read post]
1 Nov 2017, 2:58 pm
See, GE’s brief, for example, 16-712 bsac General Electric Company; also, 16-712 bsac BSA The Software Alliance; 16-712 bsac Unified Patents Inc.; and 16-712 bsac SAP America, Inc., et al. [read post]
4 Dec 2019, 9:15 am
Earlier this month, Mallinckrodt succeeded in its inter partes review (IPR) challenge against patent owner Biovie, Inc. [read post]
13 Mar 2019, 9:10 am
Mylan Pharmaceuticals, Inc., et al., No. 18-899 (May tribal sovereign immunity may be asserted to bar IPR review of patents owned by the tribe?) [read post]
13 Jul 2018, 5:54 pm
The outcome:Jazz Pharmaceuticals, Inc. [read post]
7 Feb 2019, 5:36 pm
In Momenta Pharmaceuticals, Inc. v. [read post]
